{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:25:03Z","timestamp":1794072303611,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Basic Research Program of Shenzhen Science and Technology Innovation Commission","award":["JCYJ20200109150717745"],"award-info":[{"award-number":["JCYJ20200109150717745"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471629"],"award-info":[{"award-number":["82471629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171583"],"award-info":[{"award-number":["82171583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Medical Research Fund","award":["D2403015"],"award-info":[{"award-number":["D2403015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Friedreich\u2019s ataxia (FA) is a progressive autosomal recessive neurodegenerative disorder caused by frataxin (\n                    <jats:italic>FXN<\/jats:italic>\n                    ) deficiency, resulting in mitochondrial dysfunction, oxidative stress, defective autophagy, and progressive motor impairment. Despite extensive efforts, effective disease-modifying therapies for FA remain lacking. Here, we investigate the therapeutic efficacy and underlying mechanisms of UA-36, a novel water-soluble and bioavailable derivative of urolithin A, in cellular and animal models of FA. In\n                    <jats:italic>Fxn<\/jats:italic>\n                    -knockdown N2a cells, UA-36 significantly restored FXN protein levels, enhanced autophagic flux, improved mitochondrial function, and attenuated oxidative stress\u2013induced damage. In vivo, oral administration of UA-36 for eight weeks in YG8R transgenic mice, a well-established FA model, markedly improved motor coordination, gait performance, and skeletal muscle strength. Histological and ultrastructural analyses revealed substantial protection against cerebellar Purkinje cell loss and iron deposition, cardiac hypertrophy, and the degree of skeletal muscle atrophy and fibrosis. Proteomic analysis of cerebellar tissue demonstrated that UA-36 robustly reprograms the FA-associated molecular landscape by upregulating pathways related to autophagy, mitochondrial biogenesis, oxidative phosphorylation, and redox homeostasis, while suppressing apoptosis and neuroinflammatory signaling. Together, these findings identify UA-36 as a promising lead compound and provide compelling evidence that therapeutic enhancement of autophagy and mitochondrial quality control represents a viable, mechanism-based strategy for the treatment of FA.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00457-w","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:56:51Z","timestamp":1780559811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autophagy activation by urolithin-a derivative UA-36 mitigates Friedreich\u2019s ataxia pathologies induced by frataxin deficiency"],"prefix":"10.1186","volume":"7","author":[{"given":"Qichao","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bocheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-374X","authenticated-orcid":false,"given":"Shupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"457_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pediatrneurol.2025.10.020","volume":"174","author":"SH Subramony","year":"2026","unstructured":"Subramony SH, Lynch DR. Friedreich ataxia. Pediatr Neurol. 2026;174:148\u201354. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2025.10.020.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"457_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14656566.2024.2343782","volume":"25","author":"K Gunther","year":"2024","unstructured":"Gunther K, Lynch DR. Pharmacotherapeutic strategies for Friedreich ataxia: a review of the available data. Expert Opin Pharmacother. 2024;25(5):529\u201339. https:\/\/doi.org\/10.1080\/14656566.2024.2343782.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"457_CR3","doi-asserted-by":"publisher","DOI":"10.1042\/ns20180060","volume":"2","author":"E Clark","year":"2018","unstructured":"Clark E, Johnson J, Dong YN, Mercado-Ayon E, Warren N, Zhai M, et al. Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease. Neuronal Signal. 2018;2(4):Ns20180060. https:\/\/doi.org\/10.1042\/ns20180060.","journal-title":"Neuronal Signal"},{"issue":"1-2","key":"457_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","volume":"303","author":"AH Koeppen","year":"2011","unstructured":"Koeppen AH. Friedreich\u2019s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303(1\u20132):1\u201312. https:\/\/doi.org\/10.1016\/j.jns.2011.01.010.","journal-title":"J Neurol Sci"},{"issue":"3","key":"457_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/14737175.2024.2310617","volume":"24","author":"DR Lynch","year":"2024","unstructured":"Lynch DR, Perlman S, Schadt K. Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations. Expert Rev Neurother. 2024;24(3):251\u20138. https:\/\/doi.org\/10.1080\/14737175.2024.2310617.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"457_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","volume":"30","author":"F Pilotto","year":"2024","unstructured":"Pilotto F, Chellapandi DM, Puccio H. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia. Trends Mol Med. 2024;30(2):117\u201325. https:\/\/doi.org\/10.1016\/j.molmed.2023.12.002.","journal-title":"Trends Mol Med"},{"issue":"5","key":"457_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2217\/nmt-2022-0011","volume":"12","author":"M Keita","year":"2022","unstructured":"Keita M, McIntyre K, Rodden LN, Schadt K, Lynch DR. Friedreich ataxia: clinical features and new developments. Neurodegener Dis Manag. 2022;12(5):267\u201383. https:\/\/doi.org\/10.2217\/nmt-2022-0011.","journal-title":"Neurodegener Dis Manag"},{"issue":"R1","key":"457_CR8","doi-asserted-by":"publisher","first-page":"R103","DOI":"10.1093\/hmg\/ddq165","volume":"19","author":"S Schmucker","year":"2010","unstructured":"Schmucker S, Puccio H. Understanding the molecular mechanisms of Friedreich\u2019s ataxia to develop therapeutic approaches. Hum Mol Genet. 2010;19(R1):R103\u201310. https:\/\/doi.org\/10.1093\/hmg\/ddq165.","journal-title":"Hum Mol Genet"},{"key":"457_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5065190","volume":"2018","author":"P Calap-Quintana","year":"2018","unstructured":"Calap-Quintana P, Navarro JA, Gonz\u00e1lez-Fern\u00e1ndez J, Mart\u00ednez-Sebasti\u00e1n MJ, Molt\u00f3 MD, Llorens JV. Drosophila melanogaster models of Friedreich\u2019s ataxia. BioMed Res Int. 2018;2018:5065190. https:\/\/doi.org\/10.1155\/2018\/5065190.","journal-title":"BioMed Res Int"},{"issue":"Suppl 1","key":"457_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00415-009-1004-1","volume":"256","author":"H Puccio","year":"2009","unstructured":"Puccio H. Multicellular models of Friedreich ataxia. J Neurol. 2009;256(Suppl 1):18\u201324. https:\/\/doi.org\/10.1007\/s00415-009-1004-1.","journal-title":"J Neurol"},{"issue":"3","key":"457_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1083\/jcb.201306121","volume":"204","author":"V Debattisti","year":"2014","unstructured":"Debattisti V, Pendin D, Ziviani E, Daga A, Scorrano L. Reduction of endoplasmic reticulum stress attenuates the defects caused by Drosophila mitofusin depletion. J Cell Biol. 2014;204(3):303\u201312. https:\/\/doi.org\/10.1083\/jcb.201306121.","journal-title":"J Cell Biol"},{"key":"457_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.748149","volume":"12","author":"Q Xie","year":"2021","unstructured":"Xie Q, Chen Y, Tan H, Liu B, Zheng LL, Mu Y. Targeting autophagy with natural compounds in cancer: a renewed perspective from molecular mechanisms to targeted therapy. Front Pharmacol. 2021;12:748149. https:\/\/doi.org\/10.3389\/fphar.2021.748149.","journal-title":"Front Pharmacol"},{"issue":"5","key":"457_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2023.101480","volume":"69","author":"M Liu","year":"2023","unstructured":"Liu M, Chen Z, Zhang H, Cai Z, Liu T, Zhang M, et al. Urolithin A alleviates early brain injury after subarachnoid hemorrhage by regulating the AMPK\/mTOR pathway-mediated autophagy. Neurochirurgie. 2023;69(5):101480. https:\/\/doi.org\/10.1016\/j.neuchi.2023.101480.","journal-title":"Neurochirurgie"},{"issue":"1","key":"457_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","volume":"6","author":"C Xie","year":"2022","unstructured":"Xie C, Zhuang XX, Niu Z, Ai R, Lautrup S, Zheng S, et al. Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat Biomed Eng. 2022;6(1):76\u201393. https:\/\/doi.org\/10.1038\/s41551-021-00819-5.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"457_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1208\/s12249-020-01890-y","volume":"22","author":"S Yi","year":"2021","unstructured":"Yi S, Zhang C, Hu J, Meng Y, Chen L, Yu H, et al. Preparation, Characterization, and In Vitro Pharmacodynamics and Pharmacokinetics Evaluation of PEGylated Urolithin A Liposomes. AAPS PharmSciTech. 2021;22(1):26. https:\/\/doi.org\/10.1208\/s12249-020-01890-y.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"457_CR16","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2014.9.Focus14504","volume":"37","author":"EB Golden","year":"2014","unstructured":"Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Sch\u00f6nthal AH, et al. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus. 2014;37(6):E12. https:\/\/doi.org\/10.3171\/2014.9.Focus14504.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"457_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10753-019-01111-0","volume":"43","author":"S He","year":"2019","unstructured":"He S, Zhou Q, Luo B, Chen B, Li L, Yan F. Chloroquine and 3-Methyladenine attenuates periodontal inflammation and bone loss in experimental periodontitis. Inflammation. 2019;43(1):220\u201330. https:\/\/doi.org\/10.1007\/s10753-019-01111-0.","journal-title":"Inflammation"},{"issue":"4","key":"457_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2025.2462357","volume":"13","author":"WS Ercanbrack","year":"2025","unstructured":"Ercanbrack WS, Ramirez M, Dungan A, Gaul E, Ercanbrack SJ, Wingert RA. Frataxin deficiency and the pathology of Friedreich\u2019s Ataxia across tissues. Tissue Barriers. 2025;13(4):2462357. https:\/\/doi.org\/10.1080\/21688370.2025.2462357.","journal-title":"Tissue Barriers"},{"key":"457_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnmol.2017.00264","volume":"10","author":"B Moll\u00e1","year":"2017","unstructured":"Moll\u00e1 B, Mu\u00f1oz-Lasso DC, Riveiro F, Bolinches-Amor\u00f3s A, Pallard\u00f3 FV, Fernandez-Vilata A, et al. Reversible Axonal Dystrophy by Calcium Modulation in Frataxin-Deficient Sensory Neurons of YG8R Mice. Front Mol Neurosci. 2017;10:264. https:\/\/doi.org\/10.3389\/fnmol.2017.00264.","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"457_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","volume":"1","author":"PA Andreux","year":"2019","unstructured":"Andreux PA, Blanco-Bose W, Ryu D, Burdet F, Ibberson M, Aebischer P, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab. 2019;1(6):595\u2013603. https:\/\/doi.org\/10.1038\/s42255-019-0073-4.","journal-title":"Nat Metab"},{"key":"457_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155721","volume":"130","author":"V Remadevi","year":"2024","unstructured":"Remadevi V, Jaikumar VS, Vini R, Krishnendhu B, Azeez JM, Sundaram S, et al. Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR \/AKT\/ERK1\/2 pathway. Phytomedicine. 2024;130:155721. https:\/\/doi.org\/10.1016\/j.phymed.2024.155721.","journal-title":"Phytomedicine"},{"key":"457_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/487534","volume":"2013","author":"CM Gomes","year":"2013","unstructured":"Gomes CM, Santos R. Neurodegeneration in Friedreich\u2019s ataxia: from defective frataxin to oxidative stress. Oxid Med Cell Longev. 2013;2013:487534. https:\/\/doi.org\/10.1155\/2013\/487534.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"457_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38292-0","volume":"14","author":"E Crosas-Molist","year":"2023","unstructured":"Crosas-Molist E, Graziani V, Maiques O, Pandya P, Monger J, Samain R, et al. AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration. Nat Commun. 2023;14(1):2740. https:\/\/doi.org\/10.1038\/s41467-023-38292-0.","journal-title":"Nat Commun"},{"issue":"8","key":"457_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/hmg\/ddab216","volume":"33","author":"C V\u00e1squez-Trincado","year":"2021","unstructured":"V\u00e1squez-Trincado C, Patel M, Sivaramakrishnan A, Bekeov\u00e1 C, Anderson-Pullinger L, Wang N, et al. Adaptation of the heart to Frataxin depletion: evidence that integrated stress response can predominate over mTORC1 activation. Hum Mol Genet. 2021;33(8):637\u201354. https:\/\/doi.org\/10.1093\/hmg\/ddab216.","journal-title":"Hum Mol Genet"},{"key":"457_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103339","volume":"76","author":"A Sanz-Alc\u00e1zar","year":"2024","unstructured":"Sanz-Alc\u00e1zar A, Portillo-Carrasquer M, Delaspre F, Pazos-Gil M, Tamarit J, Ros J, et al. Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1\/AMPK, KEAP1, and GSK3\u03b2 in the impairment of the NRF2 response. Redox Biol. 2024;76:103339. https:\/\/doi.org\/10.1016\/j.redox.2024.103339.","journal-title":"Redox Biol"},{"key":"457_CR26","doi-asserted-by":"publisher","first-page":"1459025","DOI":"10.3389\/fnagi.2024.1459025","volume":"16","author":"J Pan","year":"2024","unstructured":"Pan J, Yao Q, Wang Y, Chang S, Li C, Wu Y, et al. The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front Aging Neurosci. 2024;16:1459025. https:\/\/doi.org\/10.3389\/fnagi.2024.1459025.","journal-title":"Front Aging Neurosci"},{"key":"457_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051075","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants (Basel). 2023. https:\/\/doi.org\/10.3390\/antiox12051075.","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"457_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03952-w","volume":"12","author":"S Gumeni","year":"2021","unstructured":"Gumeni S, Papanagnou ED, Manola MS, Trougakos IP. Nrf2 activation induces mitophagy and reverses Parkin\/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes. Cell Death Dis. 2021;12(7):671. https:\/\/doi.org\/10.1038\/s41419-021-03952-w.","journal-title":"Cell Death Dis"},{"issue":"8","key":"457_CR29","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1523\/jneurosci.4549-03.2004","volume":"24","author":"D Simon","year":"2004","unstructured":"Simon D, Seznec H, Gansmuller A, Carelle N, Weber P, Metzger D, et al. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J Neurosci. 2004;24(8):1987\u201395. https:\/\/doi.org\/10.1523\/jneurosci.4549-03.2004.","journal-title":"J Neurosci"},{"key":"457_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.30054","volume":"6","author":"V Chandran","year":"2017","unstructured":"Chandran V, Gao K, Swarup V, Versano R, Dong H, Jordan MC, et al. Inducible and reversible phenotypes in a novel mouse model of Friedreich\u2019s Ataxia. Elife. 2017;6:e30054. https:\/\/doi.org\/10.7554\/eLife.30054.","journal-title":"Elife"},{"issue":"8","key":"457_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13662","volume":"21","author":"D D\u2019Amico","year":"2022","unstructured":"D\u2019Amico D, Olmer M, Fouassier AM, Vald\u00e9s P, Andreux PA, Rinsch C, et al. Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. Aging Cell. 2022;21(8):e13662. https:\/\/doi.org\/10.1111\/acel.13662.","journal-title":"Aging Cell"},{"issue":"3","key":"457_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11481-023-10068-9","volume":"18","author":"C Zheng","year":"2023","unstructured":"Zheng C, Li W, Ali T, Peng Z, Liu J, Pan Z, et al. Ibrutinib delays ALS installation and increases survival of SOD1G93A mice by modulating PI3K\/mTOR\/Akt signaling. J Neuroimmune Pharmacol. 2023;18(3):383\u201396. https:\/\/doi.org\/10.1007\/s11481-023-10068-9.","journal-title":"J Neuroimmune Pharmacol"},{"key":"457_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.abb.2018.11.007","volume":"661","author":"T Ali","year":"2019","unstructured":"Ali T, Mushtaq I, Maryam S, Farhan A, Saba K, Jan MI, et al. Interplay of N acetyl cysteine and melatonin in regulating oxidative stress-induced cardiac hypertrophic factors and microRNAs. Arch Biochem Biophys. 2019;661:56\u201365. https:\/\/doi.org\/10.1016\/j.abb.2018.11.007.","journal-title":"Arch Biochem Biophys"},{"issue":"Pt 1","key":"457_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117210","volume":"319","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Song Y, Zhang X, Wang S, Jia Z, Wang L, et al. Optimized new Shengmai powder ameliorates myocardial fibrosis in rats with heart failure by inhibition of the MAPK signaling pathway. J Ethnopharmacol. 2024;319(Pt 1):117210. https:\/\/doi.org\/10.1016\/j.jep.2023.117210.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"457_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jneumeth.2009.07.010","volume":"184","author":"A K\u00e1d\u00e1r","year":"2009","unstructured":"K\u00e1d\u00e1r A, Wittmann G, Liposits Z, Fekete C. Improved method for combination of immunocytochemistry and Nissl staining. J Neurosci Methods. 2009;184(1):115\u20138. https:\/\/doi.org\/10.1016\/j.jneumeth.2009.07.010.","journal-title":"J Neurosci Methods"},{"issue":"4","key":"457_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s11011-016-9834-x","volume":"31","author":"MA Stroh","year":"2016","unstructured":"Stroh MA, Winter MK, Swerdlow RH, McCarson KE, Zhu H. Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice. Metab Brain Dis. 2016;31(4):951\u201364. https:\/\/doi.org\/10.1007\/s11011-016-9834-x.","journal-title":"Metab Brain Dis"},{"key":"457_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4805","volume":"2008","author":"CA Paul","year":"2008","unstructured":"Paul CA, Beltz B, Berger-Sweeney J. The Nissl stain: a stain for cell bodies in brain sections. Cold Spring Harb Protoc. 2008;2008:pdb.prot4805. https:\/\/doi.org\/10.1101\/pdb.prot4805.","journal-title":"Cold Spring Harb Protoc"},{"issue":"12","key":"457_CR38","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1369\/0022155414553667","volume":"62","author":"VL Gadd","year":"2014","unstructured":"Gadd VL. Combining immunodetection with histochemical techniques. J Histochem Cytochem. 2014;62(12):902\u20136. https:\/\/doi.org\/10.1369\/0022155414553667.","journal-title":"J Histochem Cytochem"},{"issue":"12","key":"457_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13514","volume":"20","author":"K He","year":"2021","unstructured":"He K, Nie L, Ali T, Wang S, Chen X, Liu Z, et al. Adiponectin alleviated Alzheimer-like pathologies via autophagy-lysosomal activation. Aging Cell. 2021;20(12):e13514. https:\/\/doi.org\/10.1111\/acel.13514.","journal-title":"Aging Cell"},{"issue":"1","key":"457_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-023-00339-7","volume":"20","author":"K He","year":"2023","unstructured":"He K, Nie L, Ali T, Liu Z, Li W, Gao R, et al. Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation. Immun Ageing. 2023;20(1):15. https:\/\/doi.org\/10.1186\/s12979-023-00339-7.","journal-title":"Immun Ageing"},{"key":"457_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111964","volume":"132","author":"R Gao","year":"2024","unstructured":"Gao R, Ali T, Liu Z, Li A, He K, Yang C, et al. NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression. Int Immunopharmacol. 2024;132:111964. https:\/\/doi.org\/10.1016\/j.intimp.2024.111964.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"457_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01796-3","volume":"22","author":"Q Gong","year":"2024","unstructured":"Gong Q, Ali T, Hu Y, Gao R, Mou S, Luo Y, et al. RIPK1 inhibition mitigates neuroinflammation and rescues depressive-like behaviors in a mouse model of LPS-induced depression. Cell Commun Signal. 2024;22(1):427. https:\/\/doi.org\/10.1186\/s12964-024-01796-3.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"457_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-025-10180-y","volume":"20","author":"Y Hu","year":"2025","unstructured":"Hu Y, Ali T, Mou S, Gong Q, Gao R, Luo Y, et al. PKR inhibition prevents neuroinflammation and rescues depressive-like behaviors via BDNF\/TrkB signaling. J Neuroimmune Pharmacol. 2025;20(1):13. https:\/\/doi.org\/10.1007\/s11481-025-10180-y.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"9","key":"457_CR44","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/cns.13136","volume":"25","author":"A Ahsan","year":"2019","unstructured":"Ahsan A, Zheng YR, Wu XL, Tang WD, Liu MR, Ma SJ, et al. Urolithin A-activated autophagy but not mitophagy protects against ischemic neuronal injury by inhibiting ER stress in vitro and in vivo. CNS Neurosci Ther. 2019;25(9):976\u201386. https:\/\/doi.org\/10.1111\/cns.13136.","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"457_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18160","volume":"28","author":"W Li","year":"2024","unstructured":"Li W, Ali T, He K, Zheng C, Li N, Yu ZJ, et al. ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice. J Cell Mol Med. 2024;28(7):e18160. https:\/\/doi.org\/10.1111\/jcmm.18160.","journal-title":"J Cell Mol Med"},{"key":"457_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112935","author":"A Tisi","year":"2022","unstructured":"Tisi A, Ramekers D, Flati V, Versnel H, Maccarone R. mTOR signaling in BDNF-treated guinea pigs after ototoxic deafening. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10112935.","journal-title":"Biomedicines"},{"key":"457_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110206","volume":"262","author":"W Li","year":"2025","unstructured":"Li W, Zhu W, Chen J, Ali T, Li S. SARM1 deficiency induced depressive-like behavior via AMPK\u03b1\/p-eEF2 axis to synapse dysfunction. Neuropharmacology. 2025;262:110206. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110206.","journal-title":"Neuropharmacology"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00457-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:56:52Z","timestamp":1780559812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00457-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00457-w","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals were carried out in accordance with protocols approved by the Institutional Animal Care and Use Committee of Peking University Shenzhen Graduate School (approval number: 11110). This study did not involve human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests or conflicts of interest relevant to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}